RT
Renee P Tannenbaum
Director

Renee P Tannenbaum insider trades: Ani Pharmaceuticals (ANIP) stock buys and sales

Director, Ani Pharmaceuticals Last trade Dec 5, 2025 33 Form 4 filings
$146K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2012
4
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Renee reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 5, 2025ANIP↓ Sell$146K
Dec 12, 2024CRDF↑ Buy$34K
May 16, 2024ANIP↓ Sell$128K
Sep 15, 2022CRDF↑ Buy$17K
Nov 29, 2021ZGNX↓ Sell$62K
Jun 1, 2021ZGNX↑ Buy$85K
Nov 17, 2020ZGNX↓ Sell$311K
Mar 6, 2019ZGNX↓ Sell$886K
Mar 16, 2017ZGNX↑ Buy$55K
Dec 3, 2015ZGNX↑ Buy$77K
Mar 16, 2012SMED↑ Buy$38K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ANIP insiders

Open-market trades in the last 12 months

About Renee P Tannenbaum's insider trades

Renee P Tannenbaum is a director at Ani Pharmaceuticals (ANIP). Since Mar 16, 2012, Renee has reported 6 open-market purchases worth $307K and 5 sales worth $1.5M on SEC Form 4. In the last 12 months: 1 sale ($146K).

Their filings also include grants and awards (21 filings), shares returned to the company (1 filing), other transactions (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ANIP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.